Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis

Modern Rheumatology

Volumn 20, Issue 5, 2010, Pages 478-485

  Kitahama, Mariko ^a   Okamoto, Hiroshi ^a   Koseki, Yumi ^a   Inoue, Eisuke ^a   Kaneko, Hirotaka ^a   Taniguchi, Atsushi ^a   Momohara, Shigeki ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Hospital based prospective observational cohort; Last observation carried forward (LOCF) methodology; Tacrolimus

Indexed keywords

METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ANEMIA; ARTICLE; BLOATING; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PLEURISY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; STOMACH PAIN; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ARTHRITIS, RHEUMATOID; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 78049349416     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0319-1     Document Type: Article

References (29)

1. T Kino H Hatanaka M Hashimoto M Nishiyama T Goto M Okuhara, et al. 1987 FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics J Antibiot (Tokyo) 40 9 1249 1255 1:CAS:528:DyaL2sXmt1ylurc%3D
2. H Okamoto TP Cujec H Yamanaka N Kamatani 2008 Molecular aspects of rheumatoid arthritis: role of transcription factors FEBS J 275 18 4463 4470 1:CAS:528:DC%2BD1cXhtFChtL3F 10.1111/j.1742-4658.2008.06582.x 18662303
3. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331(17):1110-5.
4. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet. 1994;344(8920):423-8.
5. H Ekberg L Kyllonen S Madsen G Grave D Solbu H Holdaas 2007 Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients Transplantation 83 3 282 289 10.1097/01.tp.0000251923.14697.f5 17297402
6. AC Webster RC Woodroffe RS Taylor JR Chapman JC Craig 2005 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data BMJ 331 7520 810 1:CAS:528:DC%2BD2MXhtFyhu7nM 10.1136/bmj.38569.471007.AE 16157605 (Pubitemid 41442360)
7. S Kawai H Hashimoto H Kondo T Murayama T Kiuchi T Abe 2006 Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis J Rheumatol 33 11 2153 2161 1:CAS:528:DC%2BD28Xhtlemu77O 16960930
8. H Kondo T Abe H Hashimoto S Uchida S Irimajiri M Hara, et al. 2004 Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study J Rheumatol 31 2 243 251 1:CAS:528:DC%2BD2cXhslehtb8%3D 14760792
9. DE Furst K Saag MR Fleischmann Y Sherrer JA Block T Schnitzer, et al. 2002 Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study Arthritis Rheum 46 8 2020 2028 1:CAS:528: DC%2BD38XmvFOqtL8%3D 10.1002/art.10427 12209503
10. JM Kremer JS Habros KS Kolba JL Kaine MA Borton LJ Mengle-Gaw, et al. 2003 Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study Arthritis Rheum 48 10 2763 2768 1:CAS:528:DC%2BD3sXpt1Sku7g%3D 10.1002/art.11257 14558080 (Pubitemid 37280603)
11. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi, et al. 2003 Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis Arthritis Rheum 49 6 784 788 10.1002/art.11465 14673964
12. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 3 315 324 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 10.1002/art.1780310302 3358796
13. ML Prevoo MA van't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1 44 48 1:STN:280:DyaK2M7hvVeqtA%3D%3D 10.1002/art.1780380107 7818570
14. Prevoo ML. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum. 1995;44-8.
15. DM van der Heijde MA van't Hof PL van Riel LA Theunisse EW Lubberts MA van Leeuwen, et al. 1990 Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score Ann Rheum Dis 49 11 916 920 10.1136/ard.49.11.916 2256738
16. AM van Gestel ML Prevoo MA van't Hof MH van Rijswijk LB van de Putte PL van Riel 1996 Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria Arthritis Rheum 39 1 34 40 10.1002/art.1780390105 8546736 (Pubitemid 26036375)
17. PL van Riel AM van Gestel 2000 Clinical outcome measures in rheumatoid arthritis Ann Rheum Dis 59 Suppl 1 i28 i31 10.1136/ard.59.suppl-1.i28 11053082
18. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith, et al. 1995 American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 6 727 735 1:STN:280:DyaK2M3pvVSmtA%3D%3D 10.1002/art.1780380602 7779114
19. K Suzuki H Kameda K Amano H Nagasawa H Takei N Sekiguchi, et al. 2009 Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis Rheumatol Int 29 4 431 436 1:CAS:528: DC%2BD1MXhsFWnurw%3D 10.1007/s00296-008-0833-z 19127365
20. S Kawai K Yamamoto 2006 Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients Rheumatology (Oxford) 45 4 441 444 1:CAS:528:DC%2BD28Xis1Gltr0%3D 10.1093/rheumatology/kei172
21. JW van der Heijden BA Dijkmans RJ Scheper G Jansen 2007 Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs-from bench to bedside Nat Clin Pract Rheumatol 3 1 26 34 10.1038/ncprheum0380 17203006
22. SE Salmon WS Dalton 1996 Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis J Rheumatol Suppl 44 97 101 1:STN:280:DyaK28vivF2itg%3D%3D 8833064
23. S Tsujimura K Saito M Nawata S Nakayamada Y Tanaka 2008 Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis Ann Rheum Dis 67 3 380 388 1:CAS:528:DC%2BD1cXjs1ejs7c%3D 10.1136/ard.2007.070821 17660216 (Pubitemid 351281275)
24. S Tsujimura K Saito S Nakayamada K Nakano Y Tanaka 2005 Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus Arthritis Rheum 52 6 1676 1683 1:CAS:528:DC%2BD2MXlvFChtbs%3D 10.1002/art.21032 15934077 (Pubitemid 40852875)
25. SL Hider P Hoggard S Khoo D Back IN Bruce 2005 Drug efflux transporters in rheumatoid arthritis: comment on the article by Kremer Arthritis Rheum 52 2 670 10.1002/art.20770 15692979 author reply 2 (Pubitemid 40216335)
26. JM Kremer 2004 Toward a better understanding of methotrexate Arthritis Rheum 50 5 1370 1382 1:CAS:528:DC%2BD2cXkvFyktbs%3D 10.1002/art.20278 15146406 (Pubitemid 38608058)
27. Y Bottiger C Brattstrom G Tyden J Sawe CG Groth 1999 Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients Br J Clin Pharmacol 48 3 445 448 1:CAS:528:DyaK1MXmsFehsb8%3D 10.1046/j.1365-2125.1999.00007.x 10510159 (Pubitemid 29417731)
28. DE Yocum DE Furst WG Bensen FX Burch MA Borton LJ Mengle-Gaw, et al. 2004 Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience Rheumatology (Oxford) 43 8 992 999 1:CAS:528:DC%2BD2cXlsl2ku7w%3D 10.1093/rheumatology/keh155 (Pubitemid 39144446)
29. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008.